Concepedia

Heinz-Josef Lenz

HL

Statistics

Publications

9

Citations

3.2K

H-Index

9

Active since

1995

Affiliations

University of Southern California(Current)

USC Norris Comprehensive Cancer Center

Heinz-Josef Lenz is an author at University of Southern California specializing in oncology, medicine, and molecular oncology.

Publications per year

1995–2024

9

Publications

9

Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.

Dennis Salonga, Kathleen D. Danenberg, Martin R. Johnson et al. · PubMed · 2000 · 834 citations

Medicine, Molecular Biology, Oncology +16

Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors.

P. G. Johnston, Heinz-Josef Lenz, Cynthia G. Leichman et al. · PubMed · 1995 · 678 citations

Medicine, Molecular Biology, Oncology +17

ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy.

R. Metzger, Cynthia G. Leichman, Kathleen D. Danenberg et al. · Journal of Clinical Oncology · 1998 · 510 citations

Medicine, Molecular Biology, Oncology +10

Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin.

Cynthia G. Leichman, Heinz-Josef Lenz, Lawrence Leichman et al. · Journal of Clinical Oncology · 1997 · 481 citations

Medicine, Oncology, Pharmacology +16

Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival.

Heinz-Josef Lenz, Cynthia G. Leichman, Kathleen D. Danenberg et al. · Journal of Clinical Oncology · 1996 · 348 citations

Medicine, Oncology, Pharmacology +13

1–5 of 9